Contains fulltext : 22848___.PDF (publisher's version ) (Open Access
Contains fulltext : 25676___.PDF (publisher's version ) (Open Access
Supplemental material for Appropriateness of granulocyte colony-stimulating factor use in patients r...
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia...
Contains fulltext : 49340timmer-bonte.pdf (publisher's version ) (Closed access
Purpose: To determine whether granulocyte-macrophage colony-stimulating factor (GM-CSF) used in addi...
Purpose: To determine whether granulocyte-macrophage colony-stimulating factor (GM-CSF) used in addi...
Contains fulltext : 23963___.PDF (publisher's version ) (Open Access
Presented in part at the 35th American Society of Clinical Oncology meeting. Atlanta (GA); 1999. Cl...
Presented in part at the 35th American Society of Clinical Oncology meeting. Atlanta (GA); 1999. Cl...
Presented in part at the 35th American Society of Clinical Oncology meeting. Atlanta (GA); 1999. Cl...
Contains fulltext : 51747timmer-bonte.pdf (publisher's version ) (Closed access)Ch...
The purpose of this study was to evaluate the impact of granulocyte-colony stimulating factor (G-CSF...
The purpose of this study was to evaluate the impact of granulocyte-colony stimulating factor (G-CSF...
phage colony-stimulating factor (GM-CSF) used in addi tion to standard inpatient antibiotic therapy ...
have been shown to help prevent febrile neutropenia in cer-tain subgroups of cancer patients undergo...
Contains fulltext : 25676___.PDF (publisher's version ) (Open Access
Supplemental material for Appropriateness of granulocyte colony-stimulating factor use in patients r...
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia...
Contains fulltext : 49340timmer-bonte.pdf (publisher's version ) (Closed access
Purpose: To determine whether granulocyte-macrophage colony-stimulating factor (GM-CSF) used in addi...
Purpose: To determine whether granulocyte-macrophage colony-stimulating factor (GM-CSF) used in addi...
Contains fulltext : 23963___.PDF (publisher's version ) (Open Access
Presented in part at the 35th American Society of Clinical Oncology meeting. Atlanta (GA); 1999. Cl...
Presented in part at the 35th American Society of Clinical Oncology meeting. Atlanta (GA); 1999. Cl...
Presented in part at the 35th American Society of Clinical Oncology meeting. Atlanta (GA); 1999. Cl...
Contains fulltext : 51747timmer-bonte.pdf (publisher's version ) (Closed access)Ch...
The purpose of this study was to evaluate the impact of granulocyte-colony stimulating factor (G-CSF...
The purpose of this study was to evaluate the impact of granulocyte-colony stimulating factor (G-CSF...
phage colony-stimulating factor (GM-CSF) used in addi tion to standard inpatient antibiotic therapy ...
have been shown to help prevent febrile neutropenia in cer-tain subgroups of cancer patients undergo...
Contains fulltext : 25676___.PDF (publisher's version ) (Open Access
Supplemental material for Appropriateness of granulocyte colony-stimulating factor use in patients r...
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia...
DOI
Add to ORKG